Streetbeat News

Revenues

ABAT

American Battery Technology Company (ABTC) has been awarded a $20M tax credit by the U.S. DOE to support its battery recycling facility's expansion in Nevada. This award, part of the Qualifying Advanced Energy Project Credits program, will fund capital expenditures and equipment for ABTC's commercial scale recycling operations. ABTC's innovative recycling process aims to recover battery materials efficiently and with a low environmental impact. This funding complements over $70M in previous U.S. DOE grants, furthering ABTC's efforts to establish a domestic battery metals supply chain and support workforce development in Nevada.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:17 pm

MNY

MoneyHero is projected to exceed $100M in enterprise-wide revenues this year, indicating significant growth.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 1:06 pm

OLN

Analyst ratings for Olin (NYSE:OLN) show a mix of bullish to bearish sentiments among 9 experts, with a notable upward trend in 12-month price targets, now averaging $61.0. This reflects an 8.08% increase from the previous average. Key analysts from firms like Wells Fargo, Goldman Sachs, and Barclays have raised their price targets, indicating a positive outlook on Olin's performance. Despite a negative revenue trend with an -18.33% growth decline, Olin's financial health appears strong with high net margin, ROE, and ROA, alongside a sound debt management strategy.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 1:00 pm

PII

7 analysts have recently reviewed Polaris (NYSE:PII), showing a mix of opinions with 2 somewhat bullish and 5 indifferent ratings. The average 12-month price target is $100.29, a slight decrease from the previous target. Polaris faces revenue challenges with a -4.78% decline but excels in net margin and ROE. The company's debt management is a concern with a high debt-to-equity ratio. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting dynamic market conditions.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 1:00 pm

ABNB

Airbnb (NASDAQ:ABNB) has received mixed analyst ratings over the past three months, with a total of 20 analysts offering evaluations. The consensus shows a predominantly neutral stance, with recent adjustments in price targets reflecting a cautiously optimistic outlook. The average 12-month price target has been raised to $145.45, indicating a potential upside. Airbnb's financial performance shows solid revenue growth but challenges in profitability and efficiency metrics. The company's market position is strong, with significant scale and a robust market presence.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 1:00 pm

WSM

23 analysts have recently reviewed Williams-Sonoma (NYSE:WSM), offering a mix of ratings from bullish to bearish. The average 12-month price target is $273.83, marking a 21.76% increase from the previous target. Analysts have adjusted their ratings and price targets, reflecting their current views on the company's performance and market conditions. Williams-Sonoma operates in the home goods sector, with a strong market presence indicated by its superior market capitalization and financial performance, despite a recent revenue decline of -7.1%.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 1:00 pm

SRZN

Surrozen has published a study in 'Respiratory Research' showcasing the potential of its Wnt mimetic technologies in treating pulmonary fibrosis. This development could mark a significant step forward in the treatment of this condition, potentially impacting Surrozen's market position and future revenue streams.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 12:41 pm

MLSS

Milestone Scientific has started selling its CompuFlo Epidural Disposables at PRC Alliance Pain Relief Center, which has 8 locations in central Florida. Dr. Bakshi reported a 100% success rate with Epidural Steroid Injection procedures during the evaluation period.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 12:35 pm

BNGO

Bionano Genomics announced the publication of a study demonstrating that its Optical Genome Mapping (OGM) technology can identify genetic aberrations in sarcoma samples that could lead to improved diagnosis. These aberrations were missed by traditional cytogenetic methods. This discovery could enhance the accuracy of sarcoma diagnoses, potentially leading to better patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 12:14 pm

MTEK

Maris-Tech announced receiving a new order worth $415,800 from an existing defense industry customer, indicating continued business and potential growth in its defense sector engagements.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 12:12 pm